Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
KNSL
|
Michael P Kehoe
Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 2.76% |
$160,000
$16.0 p/Share
|
Mar 01
2019 |
FRME
|
Gary Lehman
Director |
BUY
Open market or private purchase
|
Direct | 41 Added 0.11% |
$1,667
$40.65 p/Share
|
Mar 01
2019 |
FRME
|
Patrick A Sherman
Director |
BUY
Open market or private purchase
|
Direct | 12 Added 0.03% |
$488
$40.65 p/Share
|
Mar 01
2019 |
INTU
|
Michelle M Clatterbuck
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,294 Reduced 21.23% |
$324,031
$250.41 p/Share
|
Mar 01
2019 |
INTU
|
Michelle M Clatterbuck
EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,747 Added 38.07% |
-
|
Mar 01
2019 |
CVS
|
Edward J Ludwig
Director |
BUY
Open market or private purchase
|
Direct | 4,000 Added 42.65% |
$233,080
$58.27 p/Share
|
Mar 01
2019 |
CVS
|
Fernando Aguirre
Director |
BUY
Open market or private purchase
|
Direct | 3,410 Added 19.23% |
$198,769
$58.29 p/Share
|
Mar 01
2019 |
IBM
|
Erich Clementi
Senior Vice President |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 25.47% |
$1,807,390
$139.03 p/Share
|
Mar 01
2019 |
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 210,000 Reduced 0.18% |
$26,947,202
$128.32 p/Share
|
Mar 01
2019 |
MA
|
Sandra A Arkell
Controller |
BUY
Grant, award, or other acquisition
|
Direct | 783 Added 13.05% |
-
|
Mar 01
2019 |
ARLO
|
Matthew Blake Mcrae
CEO |
BUY
Open market or private purchase
|
Direct | 45,000 Added 41.32% |
$200,700
$4.46 p/Share
|
Mar 01
2019 |
ACN
|
David Rowland
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 13,706 Added 26.46% |
-
|
Mar 01
2019 |
GOOG
|
Ann Mather
Director |
SELL
Open market or private sale
|
Direct | 38 Reduced 2.07% |
$42,746
$1124.9 p/Share
|
Mar 01
2019 |
SNX
|
Marshall Witt
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 600 Reduced 3.28% |
$59,424
$99.04 p/Share
|
Mar 01
2019 |
FSLR
|
Alexander R. Bradley
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 6,427 Reduced 50.0% |
$344,809
$53.65 p/Share
|
Mar 01
2019 |
SPOK
|
Vincent D Kelly
President & CEO |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 1.29% |
$70,650
$14.13 p/Share
|
Mar 01
2019 |
ADI
|
Ray Stata
Director |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 2.78% |
$2,153,600
$107.68 p/Share
|
Mar 01
2019 |
TRU
|
James M Peck
Director |
SELL
Open market or private sale
|
Direct | 131,661 Reduced 39.27% |
$8,511,884
$64.65 p/Share
|
Mar 01
2019 |
TRU
|
Todd M Cello
EVP & CFO |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 16.73% |
$518,480
$64.81 p/Share
|
Mar 01
2019 |
TRU
|
Todd M Cello
EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,500 Added 3.04% |
$33,750
$22.5 p/Share
|
Mar 01
2019 |
PNFP
|
Charles E Brock
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 3.22% |
-
|
Mar 01
2019 |
PNFP
|
Renda J Burkhart
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 15.59% |
-
|
Mar 01
2019 |
PNFP
|
Gregory L Burns
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 3.8% |
-
|
Mar 01
2019 |
PNFP
|
Marty G Dickens
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 5.46% |
-
|
Mar 01
2019 |
PNFP
|
Thomas C Farnsworth Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 5.52% |
-
|
Mar 01
2019 |
PNFP
|
Joseph C Galante
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 5.55% |
-
|
Mar 01
2019 |
PNFP
|
David B Ingram
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 3.58% |
-
|
Mar 01
2019 |
PNFP
|
Gary L Scott
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 2.78% |
-
|
Mar 01
2019 |
PNFP
|
Reese L Smith Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 1.92% |
-
|
Mar 01
2019 |
PNFP
|
Abney S Boxley Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 4.43% |
-
|
Mar 01
2019 |
PNFP
|
Glenda Baskin Glover
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 13.77% |
-
|
Mar 01
2019 |
PNFP
|
G Kennedy Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 32.19% |
-
|
Mar 01
2019 |
PNFP
|
Thomas R Sloan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,273 Added 1.14% |
-
|
Mar 01
2019 |
ABT
|
Hubert L Allen
EXECUTIVE VICE PRESIDENT, GC |
SELL
Open market or private sale
|
Direct | 2,246 Reduced 1.51% |
$175,188
$78.0 p/Share
|
Mar 01
2019 |
ABT
|
Roger Bird
SENIOR VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,113 Reduced 1.59% |
$86,814
$78.0 p/Share
|
Mar 01
2019 |
ABT
|
Brian J Blaser
Executive Vice President |
SELL
Open market or private sale
|
Direct | 16,155 Reduced 11.0% |
$1,263,806
$78.23 p/Share
|
Mar 01
2019 |
ABT
|
Sharon J Bracken
Senior Vice President |
SELL
Open market or private sale
|
Direct | 1,224 Reduced 2.37% |
$95,472
$78.0 p/Share
|
Mar 01
2019 |
ABT
|
Charles Brynelsen
SENIOR VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,002 Reduced 2.38% |
$78,156
$78.0 p/Share
|
Mar 01
2019 |
ABT
|
Jaime Contreras
Senior Vice President |
SELL
Open market or private sale
|
Direct | 12,561 Reduced 10.83% |
$983,401
$78.29 p/Share
|
Mar 01
2019 |
ABT
|
Funck, Jr. Robert E.
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,002 Reduced 0.72% |
$78,156
$78.0 p/Share
|
Mar 01
2019 |
ABT
|
Stephen R Fussell
Executive Vice President |
SELL
Open market or private sale
|
Direct | 2,246 Reduced 1.3% |
$175,188
$78.0 p/Share
|
Mar 01
2019 |
ABT
|
Joseph J Manning
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,223 Reduced 2.13% |
$95,394
$78.0 p/Share
|
Mar 01
2019 |
ABT
|
Daniel Gesua Sive Salvadori
EVP AND GROUP PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,664 Reduced 1.53% |
$129,792
$78.0 p/Share
|
Mar 01
2019 |
ABT
|
Jared Watkin
SENIOR VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,391 Reduced 1.83% |
$108,498
$78.0 p/Share
|
Mar 01
2019 |
ABT
|
Brian B Yoor
Executive Vice President & CFO |
SELL
Open market or private sale
|
Direct | 2,246 Reduced 1.93% |
$175,188
$78.0 p/Share
|
Mar 01
2019 |
AMR
|
Kevin S Crutchfield
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,800 Reduced 1.21% |
$170,548
$60.91 p/Share
|
Mar 01
2019 |
AMR
|
Kevin S Crutchfield
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,999 Added 2.12% |
$12,498
$2.5 p/Share
|
Mar 01
2019 |
FNKO
|
Fundamental Capital Partners, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 158,976 Reduced 4.51% |
$3,632,602
$22.85 p/Share
|
Mar 01
2019 |
SQ
|
Ajmere Dale
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,801 Reduced 3.5% |
$216,965
$77.46 p/Share
|
Mar 01
2019 |
KOS
|
Warburg Pincus & Co.
Director |
SELL
Open market or private sale
|
Indirect | 55,000,000 Reduced 81.91% |
$358,050,013
$6.51 p/Share
|
Mar 01
2019 |